Search company, investor...

Stage

Grant | Alive

Total Raised

$610K

Last Raised

$510K | 16 yrs ago

About ATUM

ATUM is a company that focuses on the life sciences sector, providing an integrated pipeline of tools and solutions. The company offers services such as gene design, optimization and synthesis, protein and strain engineering and production, and GMP cell line development. These services are designed to transform biology from a discovery science to an engineering discipline. ATUM was formerly known as DNA2.0. It is based in Newark, California.

Headquarters Location

37950 Central Ct

Newark, California, 94560,

United States

650-853-8347

Loading...

Loading...

Expert Collections containing ATUM

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ATUM is included in 2 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

ATUM Patents

ATUM has filed 7 patents.

The 3 most popular patent topics include:

  • 3d printing
  • 3d printing processes
  • fused filament fabrication
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/27/2019

10/10/2023

Microwave technology, Analog circuits, Planar transmission lines, Radio frequency antenna types, Distributed element circuits

Grant

Application Date

11/27/2019

Grant Date

10/10/2023

Title

Related Topics

Microwave technology, Analog circuits, Planar transmission lines, Radio frequency antenna types, Distributed element circuits

Status

Grant

Latest ATUM News

ATUM Partners with Anagram Therapeutics to Extend Collaboration to Develop Orally Delivered Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders

Oct 4, 2023

NEWARK, Calif.--(BUSINESS WIRE)--ATUM, a global specialist and industry leader in bioengineering solutions, today announced an expanded partnership with Anagram Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to improving the lives of people with cystic fibrosis (CF) and other rare diseases. The expanded relationship follows a successful partnership that accelerated delivery of ANG003 into a clinical study recently initiated in people with cystic fibrosis. Together, the

ATUM Frequently Asked Questions (FAQ)

  • Where is ATUM's headquarters?

    ATUM's headquarters is located at 37950 Central Ct, Newark.

  • What is ATUM's latest funding round?

    ATUM's latest funding round is Grant.

  • How much did ATUM raise?

    ATUM raised a total of $610K.

  • Who are the investors of ATUM?

    Investors of ATUM include National Science Foundation.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.